A composite artificial intelligence-enabled electrocardiogram (AI-ECG) identified prevalent and predicted incident Structural heart disease (SHD) across multinational cohorts, capturing signals beyond its training targets and supporting its potential as a scalable cardiovascular screening tool.
Abstract
Background Structural heart disease (SHD) drives heart failure and cardiovascular mortality but remains underdiagnosed, and echocardiography is limited as a population-level screening tool. Objectives We evaluated whether a composite artificial intelligence-enabled electrocardiogram (AI-ECG), combining independently developed models for left ventricular systolic (LVSD) and diastolic dysfunction (LVDD), identifies prevalent and predicts incident SHD across diverse populations. Methods In this multinational cohort study, detection was assessed cross-sectionally in a Korean clinical cohort (Incheon Sejong Hospital) and a US dataset (Columbia University Irving Medical Center), and incident risk was assessed in the Korean cohort and the UK Biobank among individuals without baseline SHD or heart failure. Adults with paired ECG and echocardiography were analyzed for detection, with the composite defined as positive on either model. SHD comprised reduced left ventricular ejection fraction, moderate or severe valvular disease, left ventricular hypertrophy, or pulmonary hypertension. Detection was assessed by sensitivity and specificity, and incident risk by Cox models and the C statistic. Results Among 46,082 and 36,286 participants in the two detection cohorts, the composite detected SHD with sensitivity of 71.8% and 76.1% and specificity of 88.3% and 70.1%, with positivity across all phenotypes. Among at-risk individuals, composite positivity was associated with incident SHD (hazard ratios, 3.75 and 2.75), with C statistics of 0.69 to 0.78. Conclusions A composite AI-ECG identified prevalent and predicted incident SHD across multinational cohorts, capturing signals beyond its training targets and supporting its potential as a scalable cardiovascular screening tool; whether ECG-based risk stratification improves outcomes requires prospective evaluation.
Artificial intelligence-enhanced electrocardiography demonstrated good diagnostic performance for detecting LVDD and may support future rule-out or risk-enrichment strategies in selected populations, however, current evidence remains insufficient to support routine clinical implementation.
Johann A. C. Edjimbi, Nisarg Shah, L. Donisi et al.· European Heart Journal - Dig...· 1 citation
Adding AI-ECG signals to PREVENT-HF improves near-term heart-failure risk discrimination and reclassification, though without demonstrated benefit on clinical outcomes such as heart-failure hospitalization or mortality.
A. Bollmann, V. Pradler, D. Husser et al.· Frontiers in Cardiovascular...· 0 citations
Structural AI-ECG LVSD and LVDD scores from a single sinus-rhythm ECG predict incident AF in a time-dependent manner, with the strongest performance shortly after acquisition and more durable discrimination for LVDD.
Kyung Su Kim, J. Son, Hak-Seung Lee et al.· Diagnostics· 0 citations
ECG-RISK, a multitask survival model for 67 incident three-character ICD-10 endpoints using ECG waveforms, demographic characteristics and routinely collected laboratory data from 86,673 MIMIC-IV patients, supports the feasibility of ECG-based longitudinal risk prediction across multiple diseases.
Y. Ye, Z. Zeng, X. Tian et al.· medRxiv· 0 citations
The AI-ECG model accurately identified LVSD in ED patients in this cohort despite heterogeneous acquisition conditions and retained good discrimination in hemodynamically unstable subgroups, although findings in the smaller hypotensive subgroup should be interpreted as exploratory.
In this single-center exploratory cohort of patients with obstructive hypertrophic cardiomyopathy receiving mavacamten, ECG-Vision left ventricular demonstrated high observed sensitivity and negative predictive value for TTE-defined LVSD, although estimates were imprecise because LVSD events were infrequent.
Aakash Bavishi, John Fritzlen, Marybeth Soutar et al.· Circulation: Heart Failure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.